EVALUATION OF MODEL FOR END-STAGE LIVER DISEASE SCORE CUT OFF VALUES IN PATIENTS WITH HEPATIC ENCEPHALOPATHY

Authors

  • Muhammad Khurram Department of Medicine, Rawalpindi Medical College, Rawalpindi
  • Wajeeha Qayyum Department of Medicine, Rawalpindi Medical College, Rawalpindi
  • Muhammad Umar Department of Medicine, Rawalpindi Medical College, Rawalpindi
  • Zain ul Abedin Department of Medicine, Rawalpindi Medical College, Rawalpindi
  • Hamama Tul Bushra Department of Medicine, Rawalpindi Medical College, Rawalpindi

Abstract

Background: Model for End Stage Liver Disease (MELD) is scoring system used for prioritization of patients waiting liver transplantation. Patients with decompensated chronic liver disease (DCLD) with higher MELD score and hepatic encephalopathy (HE) have poor outcome. We planned to note association between short term mortality and various cut-off values of at admission MELD score in HCV related DCLD patients presenting with HE. Methods: In this descriptive case series, 208 Hepatitis C (HCV) related chronic liver disease (CLD) patients with HE were included. At admission serum bilirubin, creatinine and INR were sought to calculate MELD score. Patients who improved were discharged and kept under regular follow up. Outcome was categorized into alive or expired in 3 months after admission. Based on MELD score cut off values of >15, >20, >25 and >30, association with outcome was determined using Chi-square test. Results: One hundred and six (51%) patients were female. Mean patient age was 55.3±10.6 years. Outcome wise, 128 (61.5%) were alive and 80 (38.5%) expired. Mean MELD score of expired was 22.17±9.14. 55 (51%) patients with MELD score >15, 44 (65.7%) patients with >20, 30 (73.2%) patients with >25, and 21 (72.5%) patients with >30 expired. MELD score >20 had strongest association with outcome, p value less than o.01. Conclusion: At admission MELD score >20 are most significantly associated with poor outcome in DCLD patients with HE.

References

Jafri W, Subhan A, Hepatitis C in Pakistan: magnitude, genotype, disease characteristics and therapeutics response. Trop Gastoenterol 2008;29(4):194–201.

Raja NS, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. Microbiol Immunol Infec 2008;41(1):4–8.

Huo TI, Lin HC, Wu JC, Hou MC, Lee FY, Lee PC, et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006;20(2):188–94.

Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124(1):91–6.

Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Heptol 2004;40(6):897–903.

Khurram M, Ahmed K, Arshad MM, Khar HB, Hasan Z. Model for end stage liver disease and outcome of portosystemic Encephalopathy. J Postgrad Med 2008;54(1):61–2.

Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic Encephalopathy as a predictor of survival in patients with end stage liver disease. Liver Transpl 2007;13(10):1366–71.

Sanyal AJ, Banas C, Sargeant C, Luketic VA, sterling RK, Stravitz, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006;43(4):682–9.

Maqsood S, Saleem A, Iqbal A, Butt JA. Precipitating factors of hepatic encephalopathy: experience at Pakistan Institute of Medical Sciences Islamabad. J Ayub Med Coll Abbottabad 2006;18(4):58–62.

Abbas SZ, Batool SA, Pathan I, Muhammad SR, Abbas SQ. Liver diseases: Admissions and mortality in a medical ICU at a rural centre in Pakistan. Pak J Med Sci 2007;23(5):713.

Mullen KD. Review of the final report of the 1998 working party on definition, nomenclature, and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25:11–6.

Okonkwo U, Nwosu M, Bojuwoye B. The Predictive Values Of The Meld And Child-Pugh Scores In Determining Mortality From Chronic Liver Disease Patients In Anambra State, Nigeria. Internet J Gastroenterol 2010;10(2).

Cholongitasa E, Burroughs AK. The evolution in the prioritization for liver transplantation. Ann Gastroenterol 2012;25(1):6–13.

Hassett M, Ramireddy S, Mantry PS. MELD based comparison of hospitalizations from hepatic encephalopathy in patients with advanced liver disease on rifaximin and lactulose combination therapy. Hepatology 2011;54(Suppl S1):1263A–4A.

Attia KA, Ackoundou-N'guessan KC, N'dri-Yoman AT, Mahassadi AK, Messou E, Bathaix YF, et al. Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol 2008;14(2):286–91.

Degré D, Bourgeois N, Boon N, Le Moine O, Louis H, Donckier V, et al. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int 2004;17(1):31–8.

Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005;11(3):336–43.

Devrajani BR, Shah SZ, Devrajani T, Kumar D. Precipitating factors of hepatic encephalopathy at a tertiary care hospital Jamshoro, Hyderabad. J Pak Med Assoc 2009;59(10):683–6.

Onyekwere CA, Ogbera AO, Hameed L. Chronic liver disease and hepatic encephalopathy: Clinical profile and outcomes. Niger J Clin Pract 2011;14:181–5.

Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007;13(10):1366–71.

D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44(1):217–31.

Samada Suarez M, Hernández Perera JC, Ramos Robaina L, Barroso Marquez L, González Rapadol L, Cepero Valdés M, et al. Factors that predict survival in patients with cirrhosis considered for Liver Transplantation. Transplant Proc 2008;40(9):2965–7.

Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007;13(10):1366–71.

Kim HJ, Lee HW. Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol 2013;19(2):105–15.

Choi PC, Kim HJ, Choi WH, Park DI, Park JH, Cho YK, et al. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis. Liver Int 2009;29(2):221–6.

Hayat AS, Shaikh N, Memon F. Identification of precipitating factors in hepatic encephalopathy patients at Liaquat University Hospital Jamshoro. World Appl Sci J 2010:8(6):661–6.

Downloads

Published

2015-12-15

Most read articles by the same author(s)